Notes And Other Explanatory Information [Abstract]

Alligator Bioscience - Filing #690835

Concept 2022-01-01 to
2022-12-31
Notes and other explanatory information [abstract]
Disclosure of auditors' remuneration [text block]
Disclosure of authorisation of financial statements [text block]
37. Godkännande av finansiella rapporter
Disclosure of basis of consolidation [text block]
Koncernredovisning
Disclosure of cash and cash equivalents [text block]
Per räkenskapsårets utgång uppgår likvida medel till:
Disclosure of cash flow statement [text block]
Koncernens totala kassautflöde för leasingkontrakt för 2022 uppgick till -8 964 TSEK (-7 020).
Disclosure of contingent liabilities [text block]
31. Ställda säkerheter och eventualförpliktelser
Disclosure of credit risk [text block]
Kredit- och motpartsrisk
Disclosure of deferred income [text block]
30. Upplupna kostnader och förutbetalda intäkter
Disclosure of deferred taxes [text block]
Disclosure of depreciation and amortisation expense [text block]
Koncernens immateriella anläggningstillgång i form av Andelar i utvecklingsprojekt avser samarbete med
Disclosure of dividends [text block]
36. Utdelning
Disclosure of earnings per share [text block]
17. Resultat per aktie
Disclosure of effect of changes in foreign exchange rates [text block]
Marknadsrisker
Disclosure of employee benefits [text block]
Disclosure of entity's operating segments [text block]
Information om geografiska marknader, koncernen
Disclosure of events after reporting period [text block]
35. Händelser efter balansdagen
Disclosure of financial instruments [text block]
Disclosure of financial risk management [text block]
4. Finansiell riskhantering och finansiella instrument
Disclosure of general information about financial statements [text block]
Noter
Disclosure of government grants [text block]
Disclosure of impairment of assets [text block]
18. Andelar i utvecklingsprojekt
Disclosure of income tax [text block]
16. Skatt
Disclosure of information about employees [text block]
11. Antal anställda, löner, andra ersättningar och sociala kostnader
Disclosure of interest expense [text block]
Disclosure of interest income [text block]
Disclosure of issued capital [text block]
29. Eget kapital
Disclosure of leases [text block]
10. Leasing
Disclosure of liquidity risk [text block]
Likviditets- och finansieringsrisk
Disclosure of objectives, policies and processes for managing capital [text block]
5. Kapitalhantering
Disclosure of other current assets [text block]
26. Övriga fordringar
Disclosure of other non-current assets [text block]
24. Andra långfristiga fordringar
Disclosure of other operating expense [text block]
13. Övriga rörelsekostnader
Disclosure of prepayments and other assets [text block]
27. Förutbetalda kostnader och upplupna intäkter
Disclosure of property, plant and equipment [text block]
21. Förbättringar i hyrd local
Disclosure of reclassification of financial instruments [text block]
Disclosure of related party [text block]
Disclosure of research and development expense [text block]
Disclosure of revenue from contracts with customers [text block]
6. Intäkter från avtal med kunder
Disclosure of share-based payment arrangements [text block]
Aktierelaterade ersättningar
Disclosure of subsidiaries [text block]
23. Andelar koncernbolag
Disclosure of trade and other receivables [text block]
25. Kundfordringar

Talk to a Data Expert

Have a question? We'll get back to you promptly.